Panacea Journal of Medical Sciences
Official Publication of NKP Salve Institute of Medical Sciences and Research Centre
Official Publication of NKP Salve Institute of Medical Sciences and Research Centre
Print ISSN:-2249-8176
Online ISSN:-2348-7682
CODEN : PJMSD7
Current Issue
Year 2024
Volume: 14 , Issue: 2
Viewed: 438
Emailed: 0
PDF Downloaded: 442
Full Text PDF Share on Facebook Share on Twitter
Original Article
Author Details :
Volume : 10, Issue : 3, Year : 2020
Article Page : 311-314
https://10.18231/j.pjms.2020.064
Abstract
Background: Meningoencephalitis refers to the inflammation of the meninges and brain, and is considered an infectious neurological emergency. Tuberculous meningoencephalitis is caused by Mycobacterium tuberculosis and is the most common form of central nervous system (CNS) tuberculosis.
Materials and Methods: CSF samples were collected asceptically and processed with an aim to identify and isolate Mycobacterium tuberculosis from clinically suspected cases of meningoencephalitis and observe the antitubercular drug resistance pattern.
Results: The study group included 117 patients clinically diagnosed cases of chronic meningoencephalitis which were subjected to Z-N staining, culture on LJ media. From 117 cases, 21 cases were AFB positive, 20 cases were culture positive for Mycobacterium tuberculosis. Antitubercular drug susceptibility pattern was obtained using commercial kit provided by Himedia. (SL023)
Conclusion: Tuberculous meningoencephalitis associated with a high frequency of neurologic sequelae and mortality if not treated promptly.
Keywords: Meningoencephalitis, Mycobacterium tuberculosis, Anti tubercular drug susceptibility.
How to cite : Kumar S , Narasimham M V, Panigrahi A, Parida B, Antitubercular drug resistance pattern of Mycobacterium tuberculosis isolates from CSF samples of suspected meningoencephalitis patients. Panacea J Med Sci 2020;10(3):311-314
Copyright © 2020 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)
